Prevalence of Toxoplasma gondii infection and incidence of toxoplasma encephalitis in non-haemophiliac HIV-1-infected adults in Taiwan

International Journal of STD and AIDS

Volumn 16, Issue 4, 2005, Pages 302-306

  Hung, Chien Ching ^a,b   Chen, M Y ^a   Hsieh, S M ^a   Hsiao, C F ^c   Sheng, W H ^a   Chang, S C ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

AIDS; HIV infection; Seroprevalence; Taiwan; Toxoplasma encephalitis; Toxoplasma gondii; Toxoplasmosis

Indexed keywords

CLINDAMYCIN; COTRIMOXAZOLE; PROTEINASE INHIBITOR; PYRIMETHAMINE; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; DISEASE ASSOCIATION; ENCEPHALITIS; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; INFECTION RISK; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PARASITE INCIDENCE; PREVALENCE; PRIORITY JOURNAL; SEROPREVALENCE; SUPERINFECTION; TAIWAN; TOXOPLASMA ENCEPHALITIS; TOXOPLASMA GONDII; TOXOPLASMOSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; FEMALE; HIV INFECTIONS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PREVALENCE; SEROEPIDEMIOLOGIC STUDIES; TAIWAN; TOXOPLASMOSIS;

EID: 18744416009     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/0956462053654230     Document Type: Article

References (16)

1. Porter SB, Sande M. Toxoplasmosis of the central nervous system in the acquired immunodeficiency syndrome. N Engl J Med 1992;327:1643-8
2. Luft BJ, Hafner R, Korzun AH, et al. Toxoplasmic encephalitis in patients with acquired immunodeficiency syndrome. N Engl J Med 1993;329:995-1000
3. Grant IH, Gold JWM, Rosenblum M, et al. Toxoplasma gondii serology in HIV-infected patients: the development of central nervous system toxoplasmosis. AIDS 1990;4:519-21
4. Glatt AL. Toxoplasma gondii serologies in patients with HIV infection. Infect Dis Clin Pract 1992;1:237-8
5. Belanger F, Derouin F, Grangeot-Keros L, Meyer L, the HEMOCO and SEROCO Study Groups. Incidence and risk factor of toxoplasmosis in a cohort of human immunodeficiency virus-infected patients: 1988-1995. Clin Infect Dis 1999;28:575-81
6. Dworkin MS, Willamson J, Jones JL, et al. Prophylaxis with trimethoprim-sulfamethoxazole for human immunodeficiency virus-infected patients: impact of risk for infectious diseases. Clin Infect Dis 2001;33:393-8
7. Abgrall S, Rabaud C, Costagliola D, and the Clinical Epidemiology Group of the French Hospital Database on HIV. Incidence and risk factors for toxoplasmic encephalitis in human immunodeficiency virus-infected patients before and during the highly active antiretroviral therapy era. Clin Infect Dis 2001;33:1747-55
8. San-Andrés F, Rubio R, Castilla J, et al. Incidence of acquired immunodeficiency syndrome-associated opportunistic diseases and the effect of treatment on a cohort of 111 patients infected with human immunodeficiency virus, 1989-1997. Clin Infect Dis 2003;36:1177-85
9. Palella FJJ, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection: HIV Outpatient Study Investigators. N Engl J Med 1998;338:853-60
10. Centers for Disease Control and Prevention. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1992;41:1-9
11. USPHS/IDSA Prevention of Opportunistic Infections Working Group. 2002 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. MMWR 2002;51:1-64
12. Panel on Clinical Practices for Treatment of HIV Infection. Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents The Department of Health and Human Services and the Henry J Kaiser Family Foundation, 4 February 2002
13. Hung CC, Chen MY, Hsieh SM, Sheng WH, Chang SC. Clinical spectrum, morbidity and mortality of acquired immunodeficiency syndrome in Taiwan: a 5-year prospective study. J Acquir Immune Defic Syndr 2000;24:378-85
14. Hsiung PC, Tsai YF, Hung CC, Chen MY. Intention of residents in internal medicine to care for patients infected with HIV at a university hospital in Taiwan. Int J STD AIDS 2001;12:602-8
15. Quiros JCLBD, Miro JM, Pena JM, et al. A randomized trial of the discontinuation of primary and secondary prophylaxis against Pneumocystis carinii pneumonia after highly active antiretroviral therapy in patients with HIV infection. N Eng J Med 2001;344:159-67
16. Kirk O, Reiss P, Uberti-Foppa C, et al. Safe interruption of maintenance therapy against previous infection with four common HIV-associated opportunistic pathogens during potent antiretroviral therapy. Ann Intern Med 2002;137:239-50